Related Experiment Videos
Endoscopic control of upper gastrointestinal bleeding
1Department of Medicine, Georgetown University Hospital, Washington, D.C. 20007.
Insights
Gastrointestinal bleeding from peptic ulcers is common, but often self-limited. Endoscopic findings like active bleeding or visible vessels predict rebleeding risk, guiding treatment decisions for upper GI bleeding.
Area of Science:
- Gastroenterology
- Endoscopic Medicine
Background:
- Peptic ulcer disease (PUD) frequently causes gastrointestinal (GI) bleeding, affecting over 100,000 patients annually.
- While most GI bleeding episodes are self-limiting, significant blood loss before evaluation predicts persistent or recurrent bleeding.
- Endoscopy plays a crucial role in assessing upper GI bleeding, with active bleeding and visible vessels being key indicators of rebleeding risk.
Purpose of the Study:
- To review the significance of endoscopic findings in predicting upper GI bleeding outcomes.
- To categorize endoscopic therapeutic approaches for managing bleeding peptic ulcers.
- To highlight the safety and efficacy of endoscopic interventions.
Main Methods:
- Review of endoscopic findings associated with peptic ulcer bleeding.
- Analysis of predictors for persistent or recurrent GI bleeding.
- Categorization of endoscopic therapies: topical, injection, mechanical, and thermal.
Main Results:
- Active bleeding and visible vessels identified during endoscopy correlate with higher rebleeding probabilities.
- Ulcers in specific locations (posterior-duodenal bulb, high lesser curve) may pose increased management risks due to proximity to major vessels.
- Endoscopic therapies for GI bleeding are generally safe and effective.
Conclusions:
- Endoscopic evaluation is vital for stratifying GI bleeding risk in peptic ulcer disease.
- Specific endoscopic findings and ulcer locations necessitate careful therapeutic consideration.
- A range of endoscopic interventions offers safe and effective management options for upper GI bleeding.
Abstract:
It has been estimated that gastrointestinal (GI) bleeding occurs in more than 100,000 patients with peptic ulcer disease each year. In 75-80% of the cases, bleeding will be self-limited. A major predictor of persistent or recurrent bleeding is the magnitude of blood loss before the initial evaluation. Endoscopy has an important role in the evaluation of the patient with suspected or presumed upper GI bleeding. Active bleeding at the time of the endoscopy correlates with the more likely probability of persistent bleeding, which carries a higher morbidity and mortality. In addition, there has been continued interest in the finding of a visible vessel. Although there is some controversy as to what a visible vessel actually is and how closely observations will agree about its recognition, there is general agreement that it is an important endoscopic finding and that it carries a high likelihood of rebleeding. In addition to the finding of a visible vessel, many endoscopists feel that ulcers found in the posterior-inferior wall of the duodenal bulb and high on the lesser curve of the stomach should be considered in a separate category. Owing to their proximity to large vessels, some feel that endoscopic management carries a greater risk because of the possibility of inducing bleeding. A wide variety of endoscopic approaches are available for the therapy of upper GI bleeding. It is convenient to divide these therapies into four categories: (a) topical, (b) injection, (c) mechanical, and (d) thermal. Endoscopic therapy for bleeding ulcers has generally been performed with a high degree of safety.(ABSTRACT TRUNCATED AT 250 WORDS)